Business Daily Media

Business Marketing

Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090

  • Written by ACN Newswire - Press Releases

Eisai: MHLW Grants Orphan Drug Designation in Japan to Novel FGF Receptor Selective Tyrosine Kinase Inhibitor E7090

TOKYO, Feb 22, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has received orphan drug designation for a prospective indication for unresectable biliary tract cancer with FGFR2 gene fusion by the Ministry of Health, Labour and Welfare, Japan (MHLW) for its in-house discovered fibroblast growth factor (FGF) receptor (FGFR1, FGFR2,

Read more //?#

Popular

Australian Venue Co Supports Its Staff And Other Hospitality workers During COVID-19 Crisis

As the Australian hospitality industry faces its toughest challenge in decades, one of the country’s largest pub groups, Australian Venue Co. (AVC), is finding ways to support its staff and other hospitality workers during the C...

Investment by Jucy Set to Reduce Australia’s Rental Vehicle Shortage

Multi-Million Dollar Investment A multi-million dollar investment in Australia’s international tourism infrastructure is expected to ease a critical shortage of rental vehicles. Jucy, one of Australasia’s largest vehicle r...

Over two thirds of Australians don’t believe they’ll ever be ‘wealthy’

But men are twice as likely than women to believe they will be wealthy in their lifetimes Amid rising interest rates, surging inflation pushing already increasing cost of living pressures, and a housing affordability crisis...

Virtual Office
Tomorrow Business Growth